Clinical Trials Browser

Phase 2 × Ovarian Neoplasms × Trastuzumab × Clear all

NCT00189579 2007-08-17

Addition of Herceptin to a Carboplatin-Paclitaxel Regimen in Patients With Ovarian Cancer

Phase 2 Terminated

Ovarian Neoplasms, Recurrence